Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development

24 Nov 2017

Abstract excerpt

Drug development continues to be costly and slow, with medications failing due to lack of efficacy or presence of toxicity. The promise of pharmacogenomic discovery includes tailoring therapeutics based on an individual's genetic makeup, rational drug development, and repurposing medications. Rapid growth of large research cohorts, linked to electronic health record (EHR) data, fuels discovery of new genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetics, Bioinformatics, and Biomedical Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29171014
DOI: 10.1002/cpt.951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug DevelopmentPMID 29171014Read ↗

Harnessing the Power of Electronic Health Records and Genomics for Drug Discovery.Semantic proximity Read ↗

Pharmacogenomics and big genomic data: from lab to clinic and back again.Semantic proximity Read ↗

Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunitiesSemantic proximity Read ↗

Big Data in Medicine Is Driving Big ChangesSemantic proximity Read ↗

Pharmacogenetics: Opportunities for the All of Us Research Program and Other Large Data Sets to Advance the FieldSemantic proximity Read ↗

Challenges of Identifying Clinically Actionable Genetic Variants for Precision Medicine.Semantic proximity Read ↗

Pharmacogenomics: time to rethink its role in precision medicine.Semantic proximity Read ↗

Integrating electronic health record genotype and phenotype datasets to transform patient care.Semantic proximity Read ↗

Integration of Omics and Phenotypic Data for Precision Medicine.Semantic proximity Read ↗

The emerging role of electronic medical records in pharmacogenomics.Semantic proximity Read ↗

Data science approaches to pharmacogenetics.Semantic proximity Read ↗

From pharmacogenetics to pharmaco-omics: Milestones and future directionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.